Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy

Status: Recruiting
Location: See all (12) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Out of 30,000 new cases per year in France, 30% of epileptic patients are drug-resistant. Neurosurgery, which consists in resecting the epileptogenic zone, is the only chance of cure. In the case of temporal epilepsy of the language-dominant hemisphere (TLE), this procedure presents a high risk of increasing cognitive difficulties and may even be contraindicated for this reason alone. The difficulties found are impairments in lexical access (anomia) and verbal memory and affect more than 60% of patients . Preoperative cognitive rehabilitation could influence brain plasticity mechanisms but there are currently no recommendations on this topic. In this context, the investigators have developed a speech rehabilitation procedure specific to the needs of ELTPR patients. They rely on cognitive hypotheses explaining the disorders but also on models of rehabilitation-induced neural plasticity likely to improve cognitive reserve before surgery. The investigators hypothesize that preoperative cognitive language rehabilitation in ELTPR patients may decrease surgical risk and improve postoperative language prognosis. The primary objective is to demonstrate the protective efficacy of preoperative speech rehabilitation on language performance postoperatively.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Healthy Volunteers: f
View:

• Patient 16 years of age and older,

• Patient whose epileptogenic area involves the temporal structures of the hemisphere specialized for language,

• Patient whose hemispheric specialization for language is known

• Patient willing to undergo resective surgery such as anterior temporal lobectomy or resection in the temporal lobe involving the hippocampus and/or the baso-temporal language area and whose planned surgery date is compatible with the performance of the study,

• Patient with a known NTB score

• Patient who has signed an informed consent or patient whose parents or legal guardians have signed the informed consent (or a single parent or legal guardian if applicable)

• Patient whose first language is French (1st language learned by the patient),

• Patient declaring to be familiar with the use of a computer and having access to an internet connection from home

• Patient affiliated or benefiting from a social security system.

Locations
Other Locations
France
Service EFSN - Hôpital Pellegrin
RECRUITING
Bordeaux
Service de Neurologie de l'Epilepsie - CHU Grenoble-Alpes
RECRUITING
Grenoble
Département de Neurophysiologie Clinique - Hôpital Roger Salengro - CHU Lille
RECRUITING
Lille
Hôpital Neurologique Pierre Wertheimer- Service de Neurologie Fonctionnelle et Epileptologie - Hospices Civils Lyon
NOT_YET_RECRUITING
Lyon
Service Epilptologie et Rythmologie Cérébrale
RECRUITING
Marseille
Service de Neurologie - Hôpital central -CHU Nancy
NOT_YET_RECRUITING
Nancy
Département de Neurologie - Hôpital de la Pitié-Salpêtrière - APHP
NOT_YET_RECRUITING
Paris
Service de Neurochirurgie -GHU Sainte-Anne
NOT_YET_RECRUITING
Paris
Service de Neurologie - Fondation ophtalmologique de Rothschild - Fondation Rothschild
RECRUITING
Paris
Service de Neurologie - CHU de Rennes
NOT_YET_RECRUITING
Rennes
Service de Neurologie - Hôpitaux Universitaires, Hôpital de Hautepierre
RECRUITING
Strasbourg
Explorations Neurophysiologiques, Pôle des Neurosciences - Hôpital Pierre Paul Riquet, Purpan
NOT_YET_RECRUITING
Toulouse
Contact Information
Primary
Veronique Sabadell
veronique.sabadell@ap-hm.fr
0491385298
Time Frame
Start Date: 2023-03-30
Estimated Completion Date: 2027-11-30
Participants
Target number of participants: 214
Treatments
Other: Control
Patients will have speech therapy assessment in addition to standard care.
Experimental: Experimental
Patients will have speech therapy assessment and intensive speech rehabilitation
Related Therapeutic Areas
Sponsors
Leads: Assistance Publique Hopitaux De Marseille

This content was sourced from clinicaltrials.gov